| Expression pattern: |
DN |
| Associated gene: |
p53, p21, runt‐related transcription factor 3 |
| Associated microRNA: |
miR‐424, miR‐761 |
| Biological function: |
Promotes chemosensitivity to doxorubicin; associated with reduced tumor stage and better prognosis in breast cancer. |
| Molecular mechanism: |
not specified |
| Biological pathway or process: |
drug resistance (inhibits) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RNase R Treatment; Clinical Sample Validation; Cohort Study; Survival Analysis; Transfection; CCK8 |
| Clinical significance: |
Higher tumor circ-LARP4 correlates with increased DFS and OS; potential prognostic biomarker. |
| Description: |
circ-LARP4 is down-regulated in breast cancer tumor tissues and breast cancer cell lines compared with controls. Higher tumor circ-LARP4 levels are associated with earlier stage and better DFS/OS. Overexpression of circ-LARP4 increases doxorubicin sensitivity in MCF-7 and MDA-MB-231 cells. |
| Confidence score: |
0.6866 |